HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.

Therapeutic Drug Monitoring

Therapeutic Drug Monitoring

Therapeutic Drug Monitoring (TDM) is a crucial aspect of optimizing the efficacy and safety of antimicrobial therapy. Antimicrobial agents play a pivotal role in treating bacterial, fungal, and viral infections, and TDM provides a systematic approach to ensuring their therapeutic levels are maintained within a narrow range. TDM involves measuring drug concentrations in a patient's blood or other biological fluids to individualize the dosage and achieve the desired therapeutic effect. For antimicrobials, TDM is particularly relevant due to the narrow therapeutic window and interpatient variability in drug pharmacokinetics. This monitoring helps healthcare professionals make informed decisions regarding dose adjustments, ensuring optimal drug exposure while minimizing the risk of toxicity. Factors influencing the need for TDM in antimicrobial therapy include patient-specific factors (age, renal and hepatic function), drug characteristics (pharmacokinetics, pharmacodynamics), and the nature of the infection being treated. In critically ill patients, those with compromised renal function, or those receiving multiple medications, TDM becomes even more crucial to prevent suboptimal dosing or toxicity. TDM aids in addressing challenges such as bacterial resistance and the emergence of multidrug-resistant strains. By optimizing antimicrobial dosages, TDM contributes to reducing the development of resistance, ensuring that a sufficient concentration of the drug is maintained to eradicate the pathogen effectively.

Committee Members
Speaker at World Congress on Infectious Disease 2025 - Reza Nassiri

Reza Nassiri

Michigan State University, United States
Speaker at World Congress on Infectious Disease 2025 - Francis J Castellino

Francis J Castellino

University of Notre Dame, United States
Speaker at World Congress on Infectious Disease 2025 - Saurabh Chattopadhyay

Saurabh Chattopadhyay

University of Kentucky College of Medicine, United States
WCID 2025 Speakers
Speaker at World Congress on Infectious Disease 2025 - Johnson J H Wang

Johnson J H Wang

Wang Electro-Opto Corporation, United States
Speaker at World Congress on Infectious Disease 2025 - Victor J Alexander

Victor J Alexander

Capital Stem Cell Research Corporation, United States
Speaker at World Congress on Infectious Disease 2025 - Jacob R Miller

Jacob R Miller

Penn State University, United States
Speaker at World Congress on Infectious Disease 2025 - Anmol Grewal

Anmol Grewal

Abrazo Health, United States
Tags

Submit your abstract Today

Newsletter

By signing up, you agree to join our mailing list to receive information and updates.

Watsapp